Runder Tisch zur Eliminierung HPV-assoziierter Krebserkrankungen in Deutschland

Program of the 6th round table on the elimination of HPV-associated cancers in Germany (PDF)

Presentations for which permission for publication has been granted can be downloaded as PDF files:

Program

Review - Organizational matters - C. Köster

The impact of HPV vaccination program on CIN3 and cervical cancer incidence in England - P . Sasieni

First indications of a possible effect of HPV vaccination on cancer incidence in Germany - A. Waldmann (PDF)

Analysis of German-language Twitter posts about vaccination against human papillomavirus (HPV) - N . Ouédraogo (PDF)

School health professionals in Germany and their contribution to (HPV) school vaccination - K. Moser (PDF)

News from school HPV vaccination education and vaccination motivation of the ÄGGF in Bavaria - H. Kramer

Evaluation of a Bremen school vaccination program to increase HPV vaccination rates - A. Takla

HPV vaccination: Current data and NaLI concept to promote vaccination knowledge and willingness to vaccinate - M. Röbl-Mathieu (PDF)

Concluding discussion - Summary - Outlook - J. Riemann

Program of the 5th round table on the elimination of HPV-associated cancers in Germany (PDF)

Presentations for which permission for publication has been granted can be downloaded as PDF files:

Program

Commemoration of Prof. Dr. Harald zur Hausen - J. Riemann

Review - Organizational matters - N . Ouédraogo

Student lectures in schools as a strategy to increase vaccination knowledge and willingness - S . Hennes (PDF)

HPV education - examples from the Ludwigsburg district - U. Traub (PDF)

#LetsTalkAboutHPV - Influencer campaign of the Baden-Württemberg Cancer Association - V. Lenkenhoff (PDF)

Voluntary HPV vaccination offer in schools from the perspective of the German population - 2nd wave of a nationwide survey - N . Ouédraogo (PDF)

The National Vaccination Action Alliance - H. Thaiss

Concluding discussion round - J. Riemann

Summary - Outlook - C. Köster

Program of the 4th Round Table on the Elimination of HPV-Associated Cancers in Germany (PDF)

Heidelberg Declaration on the occasion of the 4th Round Table on the Elimination of HPV-Associated Cancers in Germany on October 5, 2022 (PDF)

Presentations for which permission for publication has been granted can be downloaded as PDF:

Program

Review - Organizational matters - N . Ouédraogo

Development of HPV vaccination rates in girls and boys and influence of the COVID-19 pandemic - R. Thorsten

6th Bavarian Vaccination Week: "HPV vaccination - your protection against cancer - E. Gottwald

Health education in dialog - School vaccination motivation to increase the HPV vaccination rate - H. Kramer

HPV school vaccination: A political decision? - C. Hösemann

#letsTalkAboutHPV - Influencer campaign - V. Lenkenhoff

E-health = better health? - Ethics and motivational psychology in digital cancer prevention - N . Heinzelmann, J. Dörflinger

Free educational media for health education - primary prevention vaccination - C. Köster (PDF)

HPV has many faces - Experiences and potential after one year of traveling exhibition - G. Schulze-König (PDF)

How would the German population support a voluntary HPV vaccination program in schools? Results of a nationwide survey - N . Ouédraoggo (PDF)

Further development of cancer prevention - U. Helbig

Summary - Outlook - C. Köster

Program of the 3rd round table on the elimination of HPV-associated cancers in Germany (PDF)

Memorandum on the occasion of the 3rd round table on the elimination of HPV-associated cancers in Germany on 29.09.2021 (PDF)

Presentations for which permission for publication has been granted can be downloaded as PDF

Program

Review - Organizational matters - N . Ouédraogo

National Cancer Prevention Week: "Pikst kurz, schützt lang - Macht ihr Kind stark gegen Krebs" - K. Syri

Traveling exhibition: "HPV has many faces" - G. Schulze-König (PDF)

Update - Development and current status of cancer prevention in Germany - U. Helbig

News from the preventa foundation - C. Köster (PDF)

Awareness and uptake of HPV vaccination - GeSID study - M. Gerlich

Participation of boys in the HPV vaccination Vaccine Analyzer Project - C. Wähner

Update - HPV vaccination rates in Germany Data from the KV vaccination surveillance - A. Takla

Increasing HPV vaccination motivation in times of pandemic. What to do when everyone is talking about vaccination but HPV vaccination rates are still falling? - H. Kramer

Final discussion - J. Riemann

Summary - Outlook - C. Köster

Program of the 2nd round table on the elimination of HPV-associated cancers in Germany (PDF)

Presentations for which permission for publication has been granted can be downloaded as PDF files:

Program

Greeting - M. Baumann

Review - Organizational matters - N . Ouédraogo

Alliance against HPV - News - J. Riemann

National Vaccination Steering Group and News - E. Gottwald

Update on HPV vaccination rates and initial results of a nationwide HPV prevalence study - A. Marquis

Current measures of the BZgA on HPV vaccination - results of the GeSiD study - M. Gerlich

Increasing HPV vaccination motivation through medical education and knowledge transfer in school settings - H. Kramer

Strategies to increase HPV vaccination rates in Germany - Preliminary study results - E. Schott (PDF)

A project sets a precedent - C. Köster (PDF)

HPV vaccine shortage in Germany - R. Wagner

Strategic development of prevention in Germany - focus on HPV vaccination - U. Helbig

Summary - Outlook - C. Köster

Program of the 1st round table on the elimination of HPV-associated cancers in Germany (PDF)

Press release: HPV vaccination rate: 70 percent is feasible and makes sense!

Program

Welcome and introduction - H. zur Hausen

Presentation round

HPV-associated cancers in Germany - K. Kraywinkel

HPV vaccination in Germany: Current vaccination rates, hurdles and ways to achieve high vaccination rates - O. Wichmann

Group discussions - V. Froschauer, C. Köster, N. Ouédraogo, U. Mons

Plenary discussion, agreement on objectives and next steps

Summary and closing remarks - C. Köster